Raf-Induced Cell Cycle Progression in Human TF-1 Hematopoietic Cells

被引:32
作者
Chang, Fumin [1 ]
Steelman, Linda S. [1 ]
McCubrey, James A. [1 ,2 ]
机构
[1] E Carolina Univ, Brody Sch Med, Dept Microbiol & Immunol, Greenville, NC 27858 USA
[2] E Carolina Univ, Brody Sch Med, Member Leo Jenkins Canc Ctr, Greenville, NC 27858 USA
基金
美国国家卫生研究院;
关键词
Cell cycle; Raf; p21(Cip1); p27(Kip1); Cyclins; Cdks; Hematopoietic cells;
D O I
10.4161/cc.1.3.128
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Ras/Raf/MEK/ERK is a crucial pathway regulating cell cycle progression, apoptosis, and drug resistance. The Ras oncogene is frequently mutated in human cancer, which can result in the activation of the downstream Raf/MEK/ERK cascade leading to cell cycle progression in the absence of a growth stimulus. Raf-induced proliferation has been observed in hematopoietic cells. However, the mechanisms by which Raf affects cell cycle progression are not well described. To investigate the importance of Raf/MEK/ERK signaling in human hematopoietic cell growth, the effects of three different Raf genes, A-Raf, B-Raf and Raf-1, on cell cycle progression and regulatory gene expression were examined in TF-1 cells transformed to grow in response to beta-estradiol-regulated Delta Raf: ER genes. Raf activation increased the expression of cyclin A, cyclin D, cyclin E, and p21(Cip1), which are associated with G(1) progression. Activated Delta Raf-1: ER and Delta A-Raf: ER but not Delta B-Raf: ER increased Cdk2 and Cdk4 kinase activity. The regulatory role of p16(Ink4a), a potent Cdk4 kinase inhibitor, on the kinase activity of Cdk2 and Cdk4 was also examined. Raf induced p16(Ink4a) suppressor but this did not eliminate Cdk4 kinase activity. These results indicate that human hematopoietic cells transformed to grow in response to activated Raf can be used to elucidate the mechanisms by which various cell cycle regulatory molecules effect cell cycle progression. Furthermore, the differences that the various Raf isoforms have on Cdk4 activity and other cell cycle regulatory molecules can be determined in these cells.
引用
收藏
页码:220 / 226
页数:7
相关论文
共 68 条
[1]   The Restriction Point of the Cell Cycle [J].
Blagosklonny, Mikhail V. ;
Pardee, Arthur B. .
CELL CYCLE, 2002, 1 (02) :103-110
[2]   Signal transduction, cell cycle regulatory, and anti-apoptotic pathways regulated by IL-3 in hematopoietic cells: possible sites for intervention with anti-neoplastic drugs [J].
Blalock, WL ;
Weinstein-Oppenheimer, C ;
Chang, F ;
Hoyle, PE ;
Wang, XY ;
Algate, PA ;
Franklin, RA ;
Oberhaus, SM ;
Steelman, LS ;
McCubrey, JA .
LEUKEMIA, 1999, 13 (08) :1109-1166
[3]   Effects of inducible MEK1 activation on the cytokine dependency of lymphoid cells [J].
Blalock, WL ;
Pearce, M ;
Chang, F ;
Lee, JT ;
Pohnert, SC ;
Burrows, C ;
Steelman, LS ;
Franklin, RA ;
McMahon, M ;
McCubrey, JA .
LEUKEMIA, 2001, 15 (05) :794-807
[4]   Combined effects of aberrant MEK1 activity and BCL2 overexpression on relieving the cytokine dependency of human and murine hematopoietic cells [J].
Blalock, WL ;
Moye, PW ;
Chang, F ;
Pearce, M ;
Steelman, LS ;
McMahon, M ;
McCubrey, JA .
LEUKEMIA, 2000, 14 (06) :1080-1096
[5]  
BOS JL, 1989, CANCER RES, V49, P4682
[6]   Mutations of critical amino acids affect the biological and biochemical properties of oncogenic A-Raf and Raf-1 [J].
Bosch, E ;
Cherwinski, H ;
Peterson, D ;
McMahon, M .
ONCOGENE, 1997, 15 (09) :1021-1033
[7]   2 DISTINCT RAF DOMAINS MEDIATE INTERACTION WITH RAS [J].
BRTVA, TR ;
DRUGAN, JK ;
GHOSH, S ;
TERRELL, RS ;
CAMPBELLBURK, S ;
BELL, RM ;
DER, CJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (17) :9809-9812
[8]   P21Cip1 induced by Raf is associated with increased Cdk4 activity in hematopoietic cells [J].
Chang, FM ;
McCubrey, JA .
ONCOGENE, 2001, 20 (32) :4354-4364
[9]   THE INS AND OUTS OF RAF KINASES [J].
DAUM, G ;
EISENMANNTAPPE, I ;
FRIES, HW ;
TROPPMAIR, J ;
RAPP, UR .
TRENDS IN BIOCHEMICAL SCIENCES, 1994, 19 (11) :474-480
[10]   The roles of signaling by the p42/p44 mitogen-activated protein (MAP) kinase pathway; a potential route to radio- and chemo-sensitization of tumor cells resulting in the induction of apoptosis and loss of clonogenicity [J].
Dent, P ;
Jarvis, WD ;
Birrer, MJ ;
Fisher, PB ;
Schmidt-Ullrich, RK ;
Grant, S .
LEUKEMIA, 1998, 12 (12) :1843-1850